Univ Lyon, University Claude Bernard Lyon 1, CNRS, INSA Lyon, CPE, Institute of Molecular and Supramolecular Chemistry and Biochemistry, UMR 5246, F-69622 Villeurbanne cedex, France.
Matrix Biol. 2019 Jan;75-76:170-189. doi: 10.1016/j.matbio.2017.11.005. Epub 2017 Nov 11.
The remodeling of the extracellular matrix (ECM) by several protease families releases a number of bioactive fragments, which regulate numerous biological processes such as autophagy, angiogenesis, adipogenesis, fibrosis, tumor growth, metastasis and wound healing. We review here the proteases which generate bioactive ECM fragments, their ECM substrates, the major bioactive ECM fragments, together with their biological properties and their receptors. The translation of ECM fragments into drugs is challenging and would take advantage of an integrative approach to optimize the design of pre-clinical and clinical studies. This could be done by building the contextualized interaction network of the ECM fragment repertoire including their parent proteins, remodeling proteinases, and their receptors, and by using mathematical disease models.
细胞外基质(ECM)的重塑由几种蛋白酶家族完成,释放出许多生物活性片段,这些片段调节许多生物过程,如自噬、血管生成、脂肪生成、纤维化、肿瘤生长、转移和伤口愈合。在这里,我们回顾了产生生物活性 ECM 片段的蛋白酶、它们的 ECM 底物、主要的生物活性 ECM 片段,以及它们的生物学特性和受体。将 ECM 片段转化为药物具有挑战性,需要采用综合方法来优化临床前和临床研究的设计。这可以通过构建 ECM 片段库的上下文交互网络来实现,包括其母蛋白、重塑蛋白酶及其受体,并使用数学疾病模型。